T. Selcuk (Ankara, Turkey), L. Greillier (Marseille, France)
Late Breaking Abstract: Effect of the hedgehog pathway inhibitor GDC-0449 on side populations in lung cancer cell lines F. Tian, J. Mysliwietz, J. Ellwart, F. Gamarra, R. Huber, A. Bergner (Munich, Germany)
| |
Chemical characterization of exhaled breath to discriminate patients with malignant pleural mesothelioma from subjects with similar professional asbestos exposure G. de Gennaro, S. Dragonieri, F. Longobardi, M. Musti, O. Resta, G. Stallone, L. Trizio, M. Tutino (Bari, Italy)
| |
Screening of asbestos-exposed individuals using mesothelioma biomarkers K. Hollevoet, K. Nackaerts, J. Van Cleemput, J. Thimpont, P. De Vuyst, L. Bosquée, J. Delanghe, J. van Meerbeeck (Kapelle-op-den-Bos, Brussels, Leuven, Liège, Belgium)
| |
Tranexamic acid versus bleomycin pleurodesis for malignant pleural effusion via tube drainage M. Badawy, A. Abd El Ghafar (Egypt)
| |
Usefulness of fluorescence in situ hybridization (FISH) as a molecular diagnostic approach in pleural effusions D. C. B. Rosolen, L. D. Kulikowski, G. Bottura, F. S. Vargas, R. K. Sales, L. Antonangelo (Sao Paulo, Brazil)
| |
Microsatellite alterations and cell free DNA analysis in malignant pleural effusion G. E. Carpagnano, V. Turchiarelli, D. Lacedonia, G. Rago, D. Bruno, E. Costantino, M. P. Foschino Barbaro (Foggia, Italy)
| |
Diagnostic utility of eosinophilic pleural effusion: A ten years series D. Belhabib, H. Benabdelghaffar, L. Elfekih, I. Akrout, H. Hassene, S. Fenniche, M. L. Megdiche (Ariana, Tunisia)
| |
Evaluation of flow cytometric immunophenotyping and DNA analysis for detection of malignant cells in pleural effusion and ascitis D. Sayed, M. Elattar, M. E. Ibrahim, A. Mohamed-Hussein (Assiut, Egypt)
| |
Diagnostic value of N-terminal pro-brain natriuretic peptide levels in pleural effusions of cardiac origin J. M. Alvarez Dobaño, E. San Jose, F. J. Gonzalez Barcala, A. Golpe, P. Penela, J. M. Valle, C. Rodriguez Garcia, J. Ricoy, M. E. Toubes, L. Valdes (Santiago de Compostela, Spain)
| |
Intercostal chest drain insertion and thoracic ultrasound – Training and current practice amongst respiratory trainees in 3 English deaneries M. Hasan, S. Huq, R. Mustafa, M. Naveed, M. Walshaw (Leeds, Warrington, United Kingdom)
| |
Efficacy of rapid pleurodesis in malignat pleural effusions D. Turan, B. Çaglayan, A. Fidan, U. Aka Aktürk, N. Kiral, S. Cömert, B. Salepçi (Istanbul, Turkey)
| |
Diagnostic yield and complication rate of image guided pleural biopsy M. Mason, D. Aguilar, J. Curtin, A. Wilson, A. Kamath (Norwich, United Kingdom)
| |
Comparison of CT-guided closed pleural biopsy & US-guided needle biopsy for diagnosing pleural effusions; preliminary results H. Yildirim, M. Metintas, T. Kaya, G. Ak, S. Erginel, F. Alatas, O. Cadirci (Eskisehir, Turkey)
| |
The value of a UK regional mesothelioma multidisciplinary team meeting – An audit A. Pillai, S. Smith, N. Ibrahim, M. Darby, N. Maskell (Bristol, United Kingdom)
| |
Talc insufflations via semi rigid thoracoscope versus talc slurry in the treatment of malignant pleural effusion. A retrospective comparative study M. J. Malik (Barnsley, United Kingdom)
| |
Epidemiology, histology and thoracoscopic findings in malignant pleural mesothelioma (MPM) as second tumour in a single-centre cohort R. Rodella, A. Tironi, V. Pinelli, G. F. Tassi (Brescia, Italy)
| |
Dasatanib associated chylothoraces A. N. Nguyen, M. H. Uzbeck, F. A. Almeida, D. Balachandran, L. Bashoura, S. A. Faiz, V. R. Shannon, R. C. Morice, D. E. Ost, G. A. Eapen, C. A. Jimenez (Houston, United States Of America)
| |